GLOBAL MED LAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GLOBAL MED LAB
Largest movements
- Receivables within one year +€184,475
up €184,475 (+96.6%), from €191,001 to €375,476
of which Other amounts receivable: +€169,786
- Cash +€70,140
up €70,140 (+40.9%), from €171,488 to €241,628
mainly Net result for the year (+€278,425) and Depreciation (+€1,110)
- Profit (loss) carried forward +€278,425
up €278,425 (+96.5%), from €288,635 to €567,060
- Tax, wage and social debts -€23,169
down €23,169 (-31.9%), from €72,612 to €49,443
of which Taxes: -€23,169
- Gross operating margin +€57,805
up €57,805 (+19.3%), from €300,272 to €358,078
- Taxes +€16,829
up €16,829 (+23.7%), from €71,114 to €87,943
- Financial income +€7,238
up €7,238 (+226%), from €3,206 to €10,444
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €364,885 | €621,209 | +€256,325 | +70.2% |
| Fixed assets | 21/28 | €2,069 | €4,105 | +€2,035 | +98.4% |
| Tangible fixed assets | 22/27 | €2,069 | €4,105 | +€2,035 | +98.4% |
| Furniture and vehicles | 24 | €2,069 | €4,105 | +€2,035 | +98.4% |
| Current assets | 29/58 | €362,815 | €617,105 | +€254,289 | +70.1% |
| Amounts receivable within one year | 40/41 | €191,001 | €375,476 | +€184,475 | +96.6% |
| Trade receivables | 40 | €94,718 | €109,407 | +€14,689 | +15.5% |
| Other amounts receivable | 41 | €96,283 | €266,069 | +€169,786 | +176% |
| Cash at bank and in hand | 54/58 | €171,488 | €241,628 | +€70,140 | +40.9% |
| Deferred charges and accrued income | 490/1 | €326 | €0 | -€326 | -100% |
| Total equity and liabilities | 10/49 | €364,885 | €621,209 | +€256,325 | +70.2% |
| Equity | 10/15 | €291,635 | €570,060 | +€278,425 | +95.5% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €288,635 | €567,060 | +€278,425 | +96.5% |
| Amounts payable | 17/49 | €73,250 | €51,150 | -€22,100 | -30.2% |
| Amounts payable within one year | 42/48 | €73,250 | €51,150 | -€22,100 | -30.2% |
| Trade debts | 44 | €638 | €1,707 | +€1,069 | +168% |
| Suppliers | 440/4 | €638 | €1,707 | +€1,069 | +168% |
| Taxes, remuneration and social security | 45 | €72,612 | €49,443 | -€23,169 | -31.9% |
| Taxes | 450/3 | €71,112 | €47,943 | -€23,169 | -32.6% |
| Remuneration and social security | 454/9 | €1,500 | €1,500 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €539 | €1,110 | +€571 | +106% |
| Other operating charges | 640/8 | €387 | €533 | +€145 | +37.5% |
| Non-recurring operating charges | 66A | - | €403 | +€403 | |
| Gross operating margin | 9900 | €300,272 | €358,078 | +€57,805 | +19.3% |
| Operating profit (loss) | 9901 | €299,346 | €356,032 | +€56,686 | +18.9% |
| Financial income | 75/76B | €3,206 | €10,444 | +€7,238 | +226% |
| Recurring financial income | 75 | €3,206 | €10,444 | +€7,238 | +226% |
| Financial charges | 65/66B | €364 | €109 | -€255 | -70.1% |
| Recurring financial charges | 65 | €364 | €109 | -€255 | -70.1% |
| Profit (loss) for the period before taxes | 9903 | €302,188 | €366,368 | +€64,180 | +21.2% |
| Income taxes | 67/77 | €71,114 | €87,943 | +€16,829 | +23.7% |
| Profit (loss) for the period | 9904 | €231,074 | €278,425 | +€47,351 | +20.5% |
| Profit (loss) for the period to be appropriated | 9905 | €231,074 | €278,425 | +€47,351 | +20.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.